journal article·2025-08-11Open access

Reducing Complexity in Lipid Nanoparticles: Three-Component Zwitterionic Amino Lipids for Targeted Extrahepatic mRNA Delivery

Joshua J. Robinson, Di Zhang, Pratima Basak, Amogh Vaidya, Sumanta Chatterjee, Xiaoyan Bian, Minjeong Kim, Xizhen Lian, Yehui Sun, Erick Guerrero, Xu Wang, Sang M. Lee, Shuai Liu, Junyu Gong, Mayank Tiwari, Godwin K. Babanyinah, Mihaela C. Stefan, Lukas Farbiak, Daniel J. Siegwart

Abstract

Simplicity and chemical expansion of lipid nanoparticles (LNPs) offer the potential for increased therapeutic benefit of mRNA vaccines and medicines. 3-Component Zwitterionic Amino Lipid (ZAL) LNPs offer simplicity and varied organ target scope, though there is a lack of chemical and formulation exploration with this class of lipids. Herein, we report the synthesis and evaluation of ZALs with improved biocompatibility, enhanced mRNA delivery efficacy, and extrahepatic organ-specific delivery through derivation at the secondary hydroxyl position with opivalate, chloride, bromide, and acetate. Evaluation of these novel ZAL molecules revealed organ-specific delivery trends, changes in delivery efficacy, and an engineering framework for chemically modifying lipid components that correlate with each specific chemical modification. Furthermore, the most efficacious ZAL derivative, which contains an acetate modification, displayed enhanced immune cell transfection in an organ-specific manner. This study provides a roadmap for reducing the complexity of LNPs by decreasing the number of lipid components in an LNP from the canonical 4 lipids to 3 lipids and expands the chemical scope of LNPs capable of mediating extrahepatic delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Lipid Membrane Structure and Behavior · SARS-CoV-2 and COVID-19 Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, Program in Genetic Drug Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center

The University of Texas Southwestern Medical Center

Department of Chemistry and Biochemistry

The University of Texas at Dallas

Funding

National Science Foundation Graduate Research Fellowship Program · National Cancer Institute · Welch Foundation · National Institute of Biomedical Imaging and Bioengineering · National Institute of General Medical Sciences

References (70)

Show source-provided references
1. 10.1186/s12951-023-02044-510.1186/s12951-023-02044-5 ↗
2. 10.1038/s41576-021-00439-410.1038/s41576-021-00439-4 ↗
3. 10.1038/s41573-024-00977-610.1038/s41573-024-00977-6 ↗
4. 10.1016/j.ymthe.2017.03.01310.1016/j.ymthe.2017.03.013 ↗
5. 10.3389/fphar.2018.0097110.3389/fphar.2018.00971 ↗
6. 10.1039/D3NA00198A10.1039/D3NA00198A ↗
7. 10.1007/s11095-023-03471-710.1007/s11095-023-03471-7 ↗
8. 10.1007/s11051-017-3902-y10.1007/s11051-017-3902-y ↗
9. 10.1038/s41565-019-0591-y10.1038/s41565-019-0591-y ↗
10. 10.1056/NEJMoa203538910.1056/NEJMoa2035389 ↗
11. 10.4103/ijmr.IJMR_474_2110.4103/ijmr.IJMR_474_21 ↗
12. 10.1056/NEJMoa203457710.1056/NEJMoa2034577 ↗
13. 10.1021/jacs.1c0581310.1021/jacs.1c05813 ↗
14. 10.1021/jacs.3c1356910.1021/jacs.3c13569 ↗
15. 10.1002/anie.20250530410.1002/anie.202505304 ↗
16. 10.1038/s41467-024-50093-710.1038/s41467-024-50093-7 ↗
17. 10.3390/ph1508101710.3390/ph15081017 ↗
18. 10.1073/pnas.230779812010.1073/pnas.2307798120 ↗
19. 10.1039/D3TB00649B10.1039/D3TB00649B ↗
20. 10.1016/j.biopha.2023.11506510.1016/j.biopha.2023.115065 ↗
21. 10.3390/pharmaceutics1704045910.3390/pharmaceutics17040459 ↗
22. 10.1002/anie.20161020910.1002/anie.201610209 ↗
23. 10.1016/j.jconrel.2021.11.02210.1016/j.jconrel.2021.11.022 ↗
24. 10.1016/j.ijpharm.2021.12058610.1016/j.ijpharm.2021.120586 ↗
25. 10.1016/j.dmpk.2021.10042410.1016/j.dmpk.2021.100424 ↗
26. 10.1039/C2970000010610.1039/C29700000106 ↗
27. 10.1021/tx00042a01010.1021/tx00042a010 ↗
28. 10.1021/tx970128310.1021/tx9701283 ↗
29. 10.1021/jm301206810.1021/jm3012068 ↗
30. 10.3390/pharmaceutics1504118410.3390/pharmaceutics15041184 ↗
31. 10.1371/journal.pone.018796210.1371/journal.pone.0187962 ↗
32. 10.1038/s41467-023-42948-210.1038/s41467-023-42948-2 ↗
33. 10.1073/pnas.210925611810.1073/pnas.2109256118 ↗
34. 10.1038/s41565-020-0669-610.1038/s41565-020-0669-6 ↗
35. 10.1016/j.isci.2024.10980410.1016/j.isci.2024.109804 ↗
36. 10.1038/s41596-022-00755-x10.1038/s41596-022-00755-x ↗
37. 10.1039/D4PM00128A10.1039/D4PM00128A ↗
38. 10.1186/s12951-024-02812-x10.1186/s12951-024-02812-x ↗
39. 10.1021/acs.nanolett.8b0291710.1021/acs.nanolett.8b02917 ↗
40. 10.1002/anie.20160845010.1002/anie.201608450 ↗
41. 10.2147/IJN.S18801610.2147/IJN.S188016 ↗
42. 10.3791/6481010.3791/64810 ↗
43. 10.1021/acsami.5c0646410.1021/acsami.5c06464 ↗
44. 10.1002/app.3414410.1002/app.34144 ↗
45. 10.3390/polym1405099310.3390/polym14050993 ↗
46. 10.1016/j.chemphyslip.2023.10529410.1016/j.chemphyslip.2023.105294 ↗
47. 10.1007/s11095-022-03460-210.1007/s11095-022-03460-2 ↗
48. 10.1016/j.bpj.2022.08.03710.1016/j.bpj.2022.08.037 ↗
49. 10.1016/j.ejpb.2024.11433810.1016/j.ejpb.2024.114338 ↗
50. 10.3390/vaccines1301002510.3390/vaccines13010025 ↗
51. 10.1038/s41563-020-00886-010.1038/s41563-020-00886-0 ↗
52. 10.1073/pnas.230780012010.1073/pnas.2307800120 ↗
53. 10.1002/adhm.20240022510.1002/adhm.202400225 ↗
54. 10.1016/j.addr.2016.08.01410.1016/j.addr.2016.08.014 ↗
55. 10.7554/eLife.7098210.7554/eLife.70982 ↗
56. 10.3390/vaccines1304033910.3390/vaccines13040339 ↗
57. 10.1016/j.bpj.2021.07.01610.1016/j.bpj.2021.07.016 ↗
58. 10.1016/j.bbalip.2009.09.01210.1016/j.bbalip.2009.09.012 ↗
59. 10.1016/j.addr.2015.02.00710.1016/j.addr.2015.02.007 ↗
60. 10.3389/fphys.2020.58017110.3389/fphys.2020.580171 ↗
61. 10.1111/acer.1417310.1111/acer.14173 ↗
62. 10.1039/D1BM01454D10.1039/D1BM01454D ↗
63. 10.1016/j.jconrel.2016.05.05910.1016/j.jconrel.2016.05.059 ↗
64. 10.1016/j.addr.2022.11441610.1016/j.addr.2022.114416 ↗
65. 10.1039/D2BM01846B10.1039/D2BM01846B ↗
66. 10.1021/acsnano.1c0592210.1021/acsnano.1c05922 ↗
67. 10.3390/polym1202029810.3390/polym12020298 ↗
68. 10.1016/j.jconrel.2022.09.03110.1016/j.jconrel.2022.09.031 ↗
69. 10.3389/fbioe.2022.87998810.3389/fbioe.2022.879988 ↗
70. 10.1038/mtna.2012.2810.1038/mtna.2012.28 ↗